What are the recommended colchicine dosing regimens for acute gout flares, gout prophylaxis, familial Mediterranean fever, and pericarditis, including adjustments for renal or hepatic impairment, age, weight, and drug interactions?

Colchicine Dosage

For acute gout flares, use low-dose colchicine: 1.2 mg (two tablets) immediately followed by 0.6 mg (one tablet) one hour later, for a total of 1.8 mg over one hour—this regimen is equally effective as high-dose regimens but with significantly fewer gastrointestinal side effects. 1, 2

Acute Gout Flares

Standard Dosing

• Loading dose: 1.2 mg followed by 0.6 mg one hour later
• Maximum dose: 1.8 mg over one hour
• Timing: Initiate within 12 hours of flare onset for optimal efficacy 2
• Higher doses (4.8 mg over 6 hours) provide no additional benefit and cause significantly more diarrhea (77% vs 23%) and vomiting 3

Critical Contraindications

Avoid colchicine entirely in patients with renal or hepatic impairment who are taking strong CYP3A4 inhibitors (clarithromycin, ketoconazole, ritonavir) or P-glycoprotein inhibitors (cyclosporine)—this combination can be fatal 1, 2, 4

Gout Prophylaxis

Standard Dosing

• Dose: 0.6 mg once or twice daily
• Maximum: 1.2 mg/day
• Duration: At least 6 months when initiating urate-lowering therapy 2, 4

Renal Adjustments for Prophylaxis

• Mild impairment (CrCl 50-80): No adjustment needed, monitor closely
• Moderate impairment (CrCl 30-50): No adjustment needed, monitor closely; consider 0.48 mg daily for optimal levels 5
• Severe impairment (CrCl <30): Start 0.3 mg daily; use 0.3 mg daily for optimal therapeutic levels 4, 5
• Dialysis: 0.3 mg twice weekly 4

Important caveat: The standard 0.6 mg daily dose results in subtherapeutic levels 20-70% of the time in moderate renal impairment, while 0.3 mg daily or 0.6 mg every-other-day keeps levels subtherapeutic even longer 5. The 0.48 mg dose (available as oral solution or 0.5 mg tablets in some countries) provides optimal therapeutic levels.

Familial Mediterranean Fever (FMF)

Standard Dosing

• Adults: 1.2-2.4 mg daily (single or divided doses)
• Titration: Increase by 0.3 mg/day increments as needed to control disease 4
• Pediatric dosing:
  • Ages 4-6 years: 0.3-1.8 mg daily
  • Ages 6-12 years: 0.9-1.8 mg daily
  • Ages >12 years: 1.2-2.4 mg daily 4

Starting Doses for FMF (2025 EULAR Guidelines)

• Children <5 years: ≤0.5 mg/day (≤0.6 mg if using 0.6 mg tablets)
• Children 5-10 years: 0.5-1.0 mg/day (1.2 mg if using 0.6 mg tablets)
• Children >10 years: 1.0-1.5 mg/day (1.8 mg if using 0.6 mg tablets) 6

Renal Adjustments for FMF

• Mild-moderate impairment: Monitor closely, may need dose reduction
• Severe impairment (CrCl <30): Start 0.3 mg daily, increase cautiously with monitoring 4
• Dialysis: Start 0.3 mg daily, increase cautiously with monitoring 4

Colchicine Resistance in FMF

Defined as ≥1 attack per month over 3 months despite maximum tolerated colchicine dose, or persistent subclinical inflammation 6. In these cases, add IL-1 inhibitors (anakinra, canakinumab, or rilonacept) rather than discontinuing colchicine 6.

Drug Interactions Requiring Dose Reduction

Strong CYP3A4 or P-gp Inhibitors (e.g., clarithromycin, cyclosporine, ketoconazole, ritonavir)

These interactions can be fatal 1, 7

• Gout prophylaxis: Reduce from 0.6 mg twice daily to 0.3 mg once daily
• Acute gout: Reduce from 1.2 mg + 0.6 mg to 0.6 mg × 1 dose (no second dose); repeat no sooner than 3 days
• FMF: Reduce maximum daily dose from 1.2-2.4 mg to 0.6 mg (may give as 0.3 mg twice daily) 4

Moderate CYP3A4 Inhibitors (e.g., diltiazem, erythromycin, verapamil, grapefruit juice)

• Gout prophylaxis: Reduce from 0.6 mg twice daily to 0.3 mg twice daily or 0.6 mg once daily
• Acute gout: Give 1.2 mg × 1 dose only (no second dose); repeat no sooner than 3 days
• FMF: Reduce maximum daily dose to 1.2 mg 4

Critical warning: Verapamil and diltiazem have caused neuromuscular toxicity when combined with colchicine 2, 7

Hepatic Impairment

• Mild-moderate: No adjustment for prophylaxis; monitor closely
• Severe: Consider dose reduction for prophylaxis 4

Common Pitfalls to Avoid

1. Never use high-dose colchicine regimens (1.2 mg followed by 0.6 mg hourly for 6 hours)—this causes severe diarrhea in 77% of patients with no additional efficacy 3

2. Do not treat acute flares in patients on prophylactic colchicine who are also taking CYP3A4 inhibitors—toxicity risk is unacceptably high 4

3. Do not assume 0.3 mg daily or every-other-day dosing is adequate in moderate renal impairment—these regimens result in prolonged subtherapeutic levels 5

4. Watch for neuromuscular toxicity in patients with renal impairment or those taking statins—this combination significantly increases risk 2

5. In FMF, do not discontinue colchicine when adding IL-1 inhibitors unless side effects or patient intolerance necessitate it—combination therapy may be more effective 6, 8